Indeed, plasma of severely-ill COVID-19 patients stimulates platelet degranulation (15), an effect that may involve engagement of platelet IgG receptor FcγRIIA and/or complement receptor C5aR (26). This evidence concerns the gene C5AR1 and COVID-19.